Markets:

Overview

News

Currencies

International

Treasuries

DiaMedica Therapeutics Inc. - Common Stock (NQ:DMAC)

6.710 -0.030 (-0.45%)

Streaming Delayed Price Updated: 1:13 PM EDT, Aug 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DiaMedica Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

DiaMedica Therapeutics Provides Update on ReMEDy2 Trial

October 26, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday ↗

October 07, 2022

Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.

Via Benzinga

FDA Institutes Clinical Hold On DiaMedica's Late-Stage Stroke Trial - Read Why ↗

July 07, 2022

Via Benzinga

Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

October 06, 2022

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of...

Via Benzinga

DiaMedica Therapeutics Appoints Julie Daves as SVP, Clinical Development Operations

September 14, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Present at Lake Street’s 6th Annual Best Ideas Growth Conference

September 06, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics: Q2 Earnings Insights ↗

August 10, 2022

DiaMedica Therapeutics (NASDAQ:DMAC) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:30 PM. Here's what investors need to know about the announcement.

Via Benzinga

DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2022 Financial Results

August 10, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial ↗

August 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

DiaMedica Therapeutics Earnings Preview ↗

August 09, 2022

DiaMedica Therapeutics (NASDAQ:DMAC) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.

Via Benzinga

DiaMedica Therapeutics to Report Second Quarter 2022 Financial Results and Provide a Business Update August 11, 2022

August 04, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Participate in the BTIG Biotechnology Conference 2022

August 01, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

3 Penny Stocks Insiders Are Buying: DiaMedica Therapeutics, Troika Media And More ↗

July 22, 2022

U.S. stock futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday ↗

July 08, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.

Via Benzinga

Nasdaq Surges 250 Points; Crude Oil Rises Sharply ↗

July 07, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping 250 points following the release of data on initial jobless claims.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

July 07, 2022

Thursday's session saw 49 companies set new 52-week lows.

Via Benzinga

Dow Jumps More Than 200 Points; Samsung Sees This Much Surge In Quarterly Revenue ↗

July 07, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones jumping more than 200 points following the release of data on initial jobless claims.

Via Benzinga

Why U.S. Stocks Are Trading Higher After Rise In Jobless Claims ↗

July 07, 2022

U.S. stocks traded higher this morning, following the release of data on initial jobless claims.

Via Benzinga

This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session ↗

July 07, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp.

Via Benzinga

The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill ↗

July 07, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022 ↗

July 07, 2022

Upgrades

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

July 07, 2022

Good morning, trader! We're taking a look at the biggest pre-market stock movers for Thursday that investors need to know about!

Via InvestorPlace

Why Is GameStop Surging By Around 10%? 22 Stocks Moving In Thursday's Pre-Market Session ↗

July 07, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 39.6% to $0.2471 in pre-market trading after declining over 8% on Wednesday. Allena Pharmaceuticals recently announced rescheduling of special...

Via Benzinga

DiaMedica Therapeutics Announces Clinical Hold of its Phase 2/3 ReMEDy2 Clinical Trial for DM199

July 06, 2022

From DiaMedica Therapeutics

Via Business Wire

Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday ↗

June 27, 2022

Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation...

Via Benzinga

DiaMedica Therapeutics to Attend the 19th Annual Craig-Hallum Institutional Investor Conference Wednesday, June 1, 2022

May 25, 2022

From DiaMedica Therapeutics

Via Business Wire

DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2022 Financial Results

May 04, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

Earnings Preview For DiaMedica Therapeutics ↗

May 03, 2022

DiaMedica Therapeutics (NASDAQ:DMAC) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

DiaMedica Therapeutics to Report First Quarter 2022 Financial Results and Provide a Business Update May 5, 2022

April 28, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Provides a Business Update and Announces Fourth Quarter 2021 Financial Results

March 14, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.